nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—Naftifine—Toremifene—breast cancer	0.135	0.614	CrCrCtD
Terbinafine—CYP19A1—breast cancer	0.0888	0.354	CbGaD
Terbinafine—Naftifine—Tamoxifen—breast cancer	0.0848	0.386	CrCrCtD
Terbinafine—PTGS1—breast cancer	0.0714	0.285	CbGaD
Terbinafine—CYP19A1—Exemestane—breast cancer	0.0552	0.159	CbGbCtD
Terbinafine—CYP2D6—breast cancer	0.0486	0.194	CbGaD
Terbinafine—CYP19A1—Letrozole—breast cancer	0.0469	0.135	CbGbCtD
Terbinafine—CYP19A1—Anastrozole—breast cancer	0.0418	0.12	CbGbCtD
Terbinafine—CYP3A4—breast cancer	0.0417	0.166	CbGaD
Terbinafine—CYP19A1—Raloxifene—breast cancer	0.0211	0.0608	CbGbCtD
Terbinafine—CYP19A1—Tamoxifen—breast cancer	0.014	0.0402	CbGbCtD
Terbinafine—CYP19A1—Paclitaxel—breast cancer	0.0109	0.0313	CbGbCtD
Terbinafine—CYP1A2—Anastrozole—breast cancer	0.0101	0.0291	CbGbCtD
Terbinafine—CYP1A2—Toremifene—breast cancer	0.00925	0.0266	CbGbCtD
Terbinafine—CYP2C9—Anastrozole—breast cancer	0.00911	0.0262	CbGbCtD
Terbinafine—CYP2C8—Lapatinib—breast cancer	0.00871	0.0251	CbGbCtD
Terbinafine—CYP2C19—Lapatinib—breast cancer	0.00731	0.021	CbGbCtD
Terbinafine—CYP3A4—Exemestane—breast cancer	0.00699	0.0201	CbGbCtD
Terbinafine—CYP2C9—Idarubicin—breast cancer	0.0069	0.0199	CbGbCtD
Terbinafine—CYP11A1—corpus luteum—breast cancer	0.00674	0.238	CbGeAlD
Terbinafine—CYP2C8—Raloxifene—breast cancer	0.0066	0.019	CbGbCtD
Terbinafine—CYP2D6—Idarubicin—breast cancer	0.00631	0.0182	CbGbCtD
Terbinafine—CYP3A4—Letrozole—breast cancer	0.00594	0.0171	CbGbCtD
Terbinafine—CYP3A4—Anastrozole—breast cancer	0.0053	0.0152	CbGbCtD
Terbinafine—CYP3A4—Toremifene—breast cancer	0.00484	0.0139	CbGbCtD
Terbinafine—CYP3A4—Fulvestrant—breast cancer	0.0045	0.013	CbGbCtD
Terbinafine—CYP19A1—corpus luteum—breast cancer	0.00438	0.154	CbGeAlD
Terbinafine—CYP2C8—Tamoxifen—breast cancer	0.00436	0.0125	CbGbCtD
Terbinafine—CYP3A4—Thiotepa—breast cancer	0.00401	0.0115	CbGbCtD
Terbinafine—CYP2C9—Capecitabine—breast cancer	0.00378	0.0109	CbGbCtD
Terbinafine—CYP3A4—Ixabepilone—breast cancer	0.00367	0.0106	CbGbCtD
Terbinafine—CYP2C19—Tamoxifen—breast cancer	0.00366	0.0105	CbGbCtD
Terbinafine—CYP3A4—Lapatinib—breast cancer	0.00353	0.0102	CbGbCtD
Terbinafine—CYP2C8—Paclitaxel—breast cancer	0.0034	0.00977	CbGbCtD
Terbinafine—CYP1A2—Tamoxifen—breast cancer	0.00338	0.00971	CbGbCtD
Terbinafine—CYP2C8—Fluorouracil—breast cancer	0.00322	0.00925	CbGbCtD
Terbinafine—CYP2D6—Vinorelbine—breast cancer	0.00308	0.00887	CbGbCtD
Terbinafine—CYP2C9—Tamoxifen—breast cancer	0.00304	0.00875	CbGbCtD
Terbinafine—CYP2D6—Tamoxifen—breast cancer	0.00278	0.008	CbGbCtD
Terbinafine—CYP3A4—Raloxifene—breast cancer	0.00268	0.0077	CbGbCtD
Terbinafine—CYP1A2—Fluorouracil—breast cancer	0.00249	0.00716	CbGbCtD
Terbinafine—CYP2C9—Paclitaxel—breast cancer	0.00237	0.00681	CbGbCtD
Terbinafine—CYP2C9—Fluorouracil—breast cancer	0.00224	0.00645	CbGbCtD
Terbinafine—CYP3A4—Vinorelbine—breast cancer	0.00196	0.00564	CbGbCtD
Terbinafine—CYP2D6—Vinblastine—breast cancer	0.0019	0.00546	CbGbCtD
Terbinafine—CYP3A4—Tamoxifen—breast cancer	0.00177	0.00509	CbGbCtD
Terbinafine—CYP3A4—Mitoxantrone—breast cancer	0.00173	0.00496	CbGbCtD
Terbinafine—CYP3A4—Paclitaxel—breast cancer	0.00138	0.00396	CbGbCtD
Terbinafine—CYP3A4—Irinotecan—breast cancer	0.00136	0.00391	CbGbCtD
Terbinafine—SQLE—nipple—breast cancer	0.00132	0.0464	CbGeAlD
Terbinafine—CYP3A4—Vinblastine—breast cancer	0.00121	0.00347	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—breast cancer	0.00117	0.00336	CbGbCtD
Terbinafine—CYP3A4—Docetaxel—breast cancer	0.000996	0.00286	CbGbCtD
Terbinafine—SQLE—endometrium—breast cancer	0.000795	0.028	CbGeAlD
Terbinafine—CYP3A4—Doxorubicin—breast cancer	0.000742	0.00214	CbGbCtD
Terbinafine—SQLE—uterus—breast cancer	0.000733	0.0258	CbGeAlD
Terbinafine—SQLE—pituitary gland—breast cancer	0.00072	0.0254	CbGeAlD
Terbinafine—SQLE—adipose tissue—breast cancer	0.000717	0.0253	CbGeAlD
Terbinafine—SQLE—female reproductive system—breast cancer	0.000659	0.0232	CbGeAlD
Terbinafine—SQLE—adrenal gland—breast cancer	0.000643	0.0227	CbGeAlD
Terbinafine—SQLE—female gonad—breast cancer	0.0006	0.0211	CbGeAlD
Terbinafine—SQLE—endocrine gland—breast cancer	0.000558	0.0197	CbGeAlD
Terbinafine—CYP2C8—mammary gland—breast cancer	0.000486	0.0171	CbGeAlD
Terbinafine—CYP11A1—adipose tissue—breast cancer	0.00047	0.0166	CbGeAlD
Terbinafine—CYP11A1—female reproductive system—breast cancer	0.000432	0.0152	CbGeAlD
Terbinafine—CYP2C9—mammary gland—breast cancer	0.000431	0.0152	CbGeAlD
Terbinafine—CYP11A1—adrenal gland—breast cancer	0.000421	0.0149	CbGeAlD
Terbinafine—CYP11A1—female gonad—breast cancer	0.000393	0.0139	CbGeAlD
Terbinafine—SQLE—lymph node—breast cancer	0.000385	0.0136	CbGeAlD
Terbinafine—CYP1A2—nipple—breast cancer	0.000376	0.0133	CbGeAlD
Terbinafine—CYP11A1—endocrine gland—breast cancer	0.000365	0.0129	CbGeAlD
Terbinafine—CYP19A1—endometrium—breast cancer	0.000339	0.0119	CbGeAlD
Terbinafine—PTGS1—nipple—breast cancer	0.000326	0.0115	CbGeAlD
Terbinafine—CYP19A1—uterus—breast cancer	0.000312	0.011	CbGeAlD
Terbinafine—CYP19A1—adipose tissue—breast cancer	0.000305	0.0108	CbGeAlD
Terbinafine—CYP19A1—female reproductive system—breast cancer	0.000281	0.00989	CbGeAlD
Terbinafine—CYP19A1—adrenal gland—breast cancer	0.000274	0.00965	CbGeAlD
Terbinafine—CYP19A1—female gonad—breast cancer	0.000255	0.009	CbGeAlD
Terbinafine—CYP11A1—lymph node—breast cancer	0.000253	0.00891	CbGeAlD
Terbinafine—CYP2C8—endometrium—breast cancer	0.000243	0.00855	CbGeAlD
Terbinafine—CYP19A1—endocrine gland—breast cancer	0.000237	0.00837	CbGeAlD
Terbinafine—CYP2C8—pituitary gland—breast cancer	0.000219	0.00774	CbGeAlD
Terbinafine—PTGS1—epithelium—breast cancer	0.000219	0.00773	CbGeAlD
Terbinafine—PTGS1—skin of body—breast cancer	0.000209	0.00735	CbGeAlD
Terbinafine—CYP2C8—female reproductive system—breast cancer	0.000201	0.00708	CbGeAlD
Terbinafine—PTGS1—endometrium—breast cancer	0.000197	0.00693	CbGeAlD
Terbinafine—CYP2C19—endocrine gland—breast cancer	0.000195	0.00687	CbGeAlD
Terbinafine—PTGS1—uterus—breast cancer	0.000181	0.00639	CbGeAlD
Terbinafine—CYP2C9—female reproductive system—breast cancer	0.000178	0.00629	CbGeAlD
Terbinafine—PTGS1—pituitary gland—breast cancer	0.000178	0.00627	CbGeAlD
Terbinafine—PTGS1—adipose tissue—breast cancer	0.000177	0.00625	CbGeAlD
Terbinafine—CYP2C8—endocrine gland—breast cancer	0.00017	0.00599	CbGeAlD
Terbinafine—CYP19A1—lymph node—breast cancer	0.000164	0.00579	CbGeAlD
Terbinafine—PTGS1—female reproductive system—breast cancer	0.000163	0.00574	CbGeAlD
Terbinafine—CYP1A2—endocrine gland—breast cancer	0.000159	0.00561	CbGeAlD
Terbinafine—PTGS1—adrenal gland—breast cancer	0.000159	0.00561	CbGeAlD
Terbinafine—CYP2C9—endocrine gland—breast cancer	0.000151	0.00532	CbGeAlD
Terbinafine—PTGS1—female gonad—breast cancer	0.000148	0.00523	CbGeAlD
Terbinafine—PTGS1—endocrine gland—breast cancer	0.000138	0.00486	CbGeAlD
Terbinafine—CYP3A4—female reproductive system—breast cancer	0.000136	0.0048	CbGeAlD
Terbinafine—CYP2D6—female reproductive system—breast cancer	0.000134	0.00472	CbGeAlD
Terbinafine—CYP2D6—female gonad—breast cancer	0.000122	0.0043	CbGeAlD
Terbinafine—CYP3A4—endocrine gland—breast cancer	0.000115	0.00406	CbGeAlD
Terbinafine—CYP2D6—endocrine gland—breast cancer	0.000113	0.004	CbGeAlD
Terbinafine—PTGS1—lymph node—breast cancer	9.53e-05	0.00336	CbGeAlD
Terbinafine—Erythema multiforme—Methotrexate—breast cancer	2.55e-05	0.000255	CcSEcCtD
Terbinafine—Dizziness—Irinotecan—breast cancer	2.54e-05	0.000255	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—breast cancer	2.54e-05	0.000254	CcSEcCtD
Terbinafine—Anorexia—Docetaxel—breast cancer	2.54e-05	0.000254	CcSEcCtD
Terbinafine—Nervous system disorder—Capecitabine—breast cancer	2.53e-05	0.000253	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—breast cancer	2.53e-05	0.000253	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—breast cancer	2.52e-05	0.000252	CcSEcCtD
Terbinafine—Diarrhoea—Fluorouracil—breast cancer	2.52e-05	0.000252	CcSEcCtD
Terbinafine—Thrombocytopenia—Capecitabine—breast cancer	2.52e-05	0.000252	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—breast cancer	2.52e-05	0.000252	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—breast cancer	2.51e-05	0.000251	CcSEcCtD
Terbinafine—Skin disorder—Capecitabine—breast cancer	2.5e-05	0.00025	CcSEcCtD
Terbinafine—Urticaria—Paclitaxel—breast cancer	2.49e-05	0.000249	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—breast cancer	2.48e-05	0.000248	CcSEcCtD
Terbinafine—Body temperature increased—Paclitaxel—breast cancer	2.48e-05	0.000248	CcSEcCtD
Terbinafine—Abdominal pain—Paclitaxel—breast cancer	2.48e-05	0.000248	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—breast cancer	2.46e-05	0.000246	CcSEcCtD
Terbinafine—Anorexia—Capecitabine—breast cancer	2.45e-05	0.000246	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—breast cancer	2.45e-05	0.000245	CcSEcCtD
Terbinafine—Vomiting—Irinotecan—breast cancer	2.45e-05	0.000245	CcSEcCtD
Terbinafine—Vomiting—Mitoxantrone—breast cancer	2.45e-05	0.000245	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—breast cancer	2.44e-05	0.000244	CcSEcCtD
Terbinafine—Dizziness—Fluorouracil—breast cancer	2.44e-05	0.000244	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—breast cancer	2.43e-05	0.000243	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—breast cancer	2.43e-05	0.000243	CcSEcCtD
Terbinafine—Rash—Mitoxantrone—breast cancer	2.43e-05	0.000243	CcSEcCtD
Terbinafine—Rash—Irinotecan—breast cancer	2.43e-05	0.000243	CcSEcCtD
Terbinafine—Dermatitis—Mitoxantrone—breast cancer	2.42e-05	0.000242	CcSEcCtD
Terbinafine—Dermatitis—Irinotecan—breast cancer	2.42e-05	0.000242	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Docetaxel—breast cancer	2.42e-05	0.000242	CcSEcCtD
Terbinafine—Headache—Mitoxantrone—breast cancer	2.41e-05	0.000241	CcSEcCtD
Terbinafine—Headache—Irinotecan—breast cancer	2.41e-05	0.000241	CcSEcCtD
Terbinafine—Paraesthesia—Docetaxel—breast cancer	2.39e-05	0.000239	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—breast cancer	2.39e-05	0.000239	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—breast cancer	2.38e-05	0.000239	CcSEcCtD
Terbinafine—Vomiting—Gemcitabine—breast cancer	2.38e-05	0.000238	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—breast cancer	2.36e-05	0.000236	CcSEcCtD
Terbinafine—Rash—Gemcitabine—breast cancer	2.36e-05	0.000236	CcSEcCtD
Terbinafine—Dermatitis—Gemcitabine—breast cancer	2.36e-05	0.000236	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—breast cancer	2.36e-05	0.000236	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—breast cancer	2.35e-05	0.000236	CcSEcCtD
Terbinafine—Erythema—Methotrexate—breast cancer	2.35e-05	0.000235	CcSEcCtD
Terbinafine—Headache—Gemcitabine—breast cancer	2.35e-05	0.000235	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Capecitabine—breast cancer	2.35e-05	0.000235	CcSEcCtD
Terbinafine—Vomiting—Fluorouracil—breast cancer	2.34e-05	0.000234	CcSEcCtD
Terbinafine—Dyspepsia—Docetaxel—breast cancer	2.34e-05	0.000234	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—breast cancer	2.34e-05	0.000234	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—breast cancer	2.32e-05	0.000233	CcSEcCtD
Terbinafine—Rash—Fluorouracil—breast cancer	2.32e-05	0.000232	CcSEcCtD
Terbinafine—Dermatitis—Fluorouracil—breast cancer	2.32e-05	0.000232	CcSEcCtD
Terbinafine—Paraesthesia—Capecitabine—breast cancer	2.31e-05	0.000231	CcSEcCtD
Terbinafine—Decreased appetite—Docetaxel—breast cancer	2.31e-05	0.000231	CcSEcCtD
Terbinafine—Hypersensitivity—Paclitaxel—breast cancer	2.31e-05	0.000231	CcSEcCtD
Terbinafine—Headache—Fluorouracil—breast cancer	2.31e-05	0.000231	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—breast cancer	2.3e-05	0.00023	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Docetaxel—breast cancer	2.3e-05	0.00023	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—breast cancer	2.3e-05	0.00023	CcSEcCtD
Terbinafine—Fatigue—Docetaxel—breast cancer	2.29e-05	0.000229	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—breast cancer	2.29e-05	0.000229	CcSEcCtD
Terbinafine—Nausea—Mitoxantrone—breast cancer	2.29e-05	0.000229	CcSEcCtD
Terbinafine—Nausea—Irinotecan—breast cancer	2.29e-05	0.000229	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—breast cancer	2.28e-05	0.000228	CcSEcCtD
Terbinafine—Pain—Docetaxel—breast cancer	2.27e-05	0.000228	CcSEcCtD
Terbinafine—Dyspepsia—Capecitabine—breast cancer	2.27e-05	0.000227	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—breast cancer	2.25e-05	0.000225	CcSEcCtD
Terbinafine—Asthenia—Paclitaxel—breast cancer	2.25e-05	0.000225	CcSEcCtD
Terbinafine—Decreased appetite—Capecitabine—breast cancer	2.24e-05	0.000224	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—breast cancer	2.23e-05	0.000223	CcSEcCtD
Terbinafine—Nausea—Gemcitabine—breast cancer	2.23e-05	0.000223	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Capecitabine—breast cancer	2.22e-05	0.000222	CcSEcCtD
Terbinafine—Fatigue—Capecitabine—breast cancer	2.22e-05	0.000222	CcSEcCtD
Terbinafine—Pruritus—Paclitaxel—breast cancer	2.22e-05	0.000222	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—breast cancer	2.21e-05	0.000221	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—breast cancer	2.21e-05	0.000221	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—breast cancer	2.21e-05	0.000221	CcSEcCtD
Terbinafine—Pain—Capecitabine—breast cancer	2.2e-05	0.00022	CcSEcCtD
Terbinafine—Erythema—Epirubicin—breast cancer	2.2e-05	0.00022	CcSEcCtD
Terbinafine—Feeling abnormal—Docetaxel—breast cancer	2.19e-05	0.000219	CcSEcCtD
Terbinafine—Nausea—Fluorouracil—breast cancer	2.19e-05	0.000219	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—breast cancer	2.18e-05	0.000218	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—breast cancer	2.18e-05	0.000218	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—breast cancer	2.18e-05	0.000218	CcSEcCtD
Terbinafine—Gastrointestinal pain—Docetaxel—breast cancer	2.18e-05	0.000218	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—breast cancer	2.17e-05	0.000217	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—breast cancer	2.17e-05	0.000217	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—breast cancer	2.15e-05	0.000215	CcSEcCtD
Terbinafine—Diarrhoea—Paclitaxel—breast cancer	2.15e-05	0.000215	CcSEcCtD
Terbinafine—Feeling abnormal—Capecitabine—breast cancer	2.12e-05	0.000212	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—breast cancer	2.12e-05	0.000212	CcSEcCtD
Terbinafine—Malaise—Methotrexate—breast cancer	2.12e-05	0.000212	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—breast cancer	2.11e-05	0.000211	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—breast cancer	2.11e-05	0.000211	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—breast cancer	2.11e-05	0.000211	CcSEcCtD
Terbinafine—Gastrointestinal pain—Capecitabine—breast cancer	2.11e-05	0.000211	CcSEcCtD
Terbinafine—Body temperature increased—Docetaxel—breast cancer	2.1e-05	0.00021	CcSEcCtD
Terbinafine—Abdominal pain—Docetaxel—breast cancer	2.1e-05	0.00021	CcSEcCtD
Terbinafine—Dizziness—Paclitaxel—breast cancer	2.08e-05	0.000208	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—breast cancer	2.07e-05	0.000207	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—breast cancer	2.06e-05	0.000207	CcSEcCtD
Terbinafine—Cough—Methotrexate—breast cancer	2.05e-05	0.000205	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—breast cancer	2.05e-05	0.000205	CcSEcCtD
Terbinafine—Urticaria—Capecitabine—breast cancer	2.05e-05	0.000205	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—breast cancer	2.04e-05	0.000204	CcSEcCtD
Terbinafine—Body temperature increased—Capecitabine—breast cancer	2.04e-05	0.000204	CcSEcCtD
Terbinafine—Abdominal pain—Capecitabine—breast cancer	2.04e-05	0.000204	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—breast cancer	2.03e-05	0.000203	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—breast cancer	2.03e-05	0.000203	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—breast cancer	2e-05	0.0002	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—breast cancer	2e-05	0.0002	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—breast cancer	2e-05	0.0002	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—breast cancer	2e-05	0.0002	CcSEcCtD
Terbinafine—Vomiting—Paclitaxel—breast cancer	2e-05	0.0002	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—breast cancer	1.99e-05	0.000199	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.99e-05	0.000199	CcSEcCtD
Terbinafine—Malaise—Epirubicin—breast cancer	1.98e-05	0.000198	CcSEcCtD
Terbinafine—Rash—Paclitaxel—breast cancer	1.98e-05	0.000198	CcSEcCtD
Terbinafine—Dermatitis—Paclitaxel—breast cancer	1.98e-05	0.000198	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—breast cancer	1.98e-05	0.000198	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—breast cancer	1.98e-05	0.000198	CcSEcCtD
Terbinafine—Headache—Paclitaxel—breast cancer	1.97e-05	0.000197	CcSEcCtD
Terbinafine—Hypersensitivity—Docetaxel—breast cancer	1.96e-05	0.000196	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—breast cancer	1.96e-05	0.000196	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—breast cancer	1.93e-05	0.000193	CcSEcCtD
Terbinafine—Cough—Epirubicin—breast cancer	1.92e-05	0.000192	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—breast cancer	1.92e-05	0.000192	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—breast cancer	1.92e-05	0.000192	CcSEcCtD
Terbinafine—Asthenia—Docetaxel—breast cancer	1.91e-05	0.000191	CcSEcCtD
Terbinafine—Infection—Methotrexate—breast cancer	1.9e-05	0.000191	CcSEcCtD
Terbinafine—Hypersensitivity—Capecitabine—breast cancer	1.9e-05	0.00019	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—breast cancer	1.89e-05	0.000189	CcSEcCtD
Terbinafine—Pruritus—Docetaxel—breast cancer	1.88e-05	0.000188	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—breast cancer	1.88e-05	0.000188	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—breast cancer	1.88e-05	0.000188	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—breast cancer	1.88e-05	0.000188	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—breast cancer	1.87e-05	0.000187	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—breast cancer	1.87e-05	0.000187	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—breast cancer	1.87e-05	0.000187	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—breast cancer	1.87e-05	0.000187	CcSEcCtD
Terbinafine—Nausea—Paclitaxel—breast cancer	1.86e-05	0.000186	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—breast cancer	1.86e-05	0.000186	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.86e-05	0.000186	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—breast cancer	1.85e-05	0.000185	CcSEcCtD
Terbinafine—Asthenia—Capecitabine—breast cancer	1.85e-05	0.000185	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—breast cancer	1.83e-05	0.000183	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—breast cancer	1.83e-05	0.000183	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—breast cancer	1.83e-05	0.000183	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—breast cancer	1.83e-05	0.000183	CcSEcCtD
Terbinafine—Pruritus—Capecitabine—breast cancer	1.82e-05	0.000182	CcSEcCtD
Terbinafine—Diarrhoea—Docetaxel—breast cancer	1.82e-05	0.000182	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—breast cancer	1.81e-05	0.000181	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—breast cancer	1.79e-05	0.000179	CcSEcCtD
Terbinafine—Infection—Epirubicin—breast cancer	1.78e-05	0.000178	CcSEcCtD
Terbinafine—Cough—Doxorubicin—breast cancer	1.77e-05	0.000178	CcSEcCtD
Terbinafine—Diarrhoea—Capecitabine—breast cancer	1.76e-05	0.000176	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—breast cancer	1.76e-05	0.000176	CcSEcCtD
Terbinafine—Dizziness—Docetaxel—breast cancer	1.76e-05	0.000176	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—breast cancer	1.76e-05	0.000176	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Methotrexate—breast cancer	1.75e-05	0.000175	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—breast cancer	1.74e-05	0.000174	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—breast cancer	1.73e-05	0.000173	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—breast cancer	1.73e-05	0.000173	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—breast cancer	1.73e-05	0.000173	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—breast cancer	1.73e-05	0.000173	CcSEcCtD
Terbinafine—Paraesthesia—Methotrexate—breast cancer	1.72e-05	0.000172	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.72e-05	0.000172	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—breast cancer	1.71e-05	0.000171	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—breast cancer	1.71e-05	0.000171	CcSEcCtD
Terbinafine—Dizziness—Capecitabine—breast cancer	1.7e-05	0.00017	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—breast cancer	1.69e-05	0.000169	CcSEcCtD
Terbinafine—Vomiting—Docetaxel—breast cancer	1.69e-05	0.000169	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—breast cancer	1.69e-05	0.000169	CcSEcCtD
Terbinafine—Rash—Docetaxel—breast cancer	1.68e-05	0.000168	CcSEcCtD
Terbinafine—Dermatitis—Docetaxel—breast cancer	1.68e-05	0.000168	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—breast cancer	1.67e-05	0.000167	CcSEcCtD
Terbinafine—Decreased appetite—Methotrexate—breast cancer	1.67e-05	0.000167	CcSEcCtD
Terbinafine—Headache—Docetaxel—breast cancer	1.67e-05	0.000167	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—breast cancer	1.66e-05	0.000166	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—breast cancer	1.66e-05	0.000166	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—breast cancer	1.65e-05	0.000165	CcSEcCtD
Terbinafine—Infection—Doxorubicin—breast cancer	1.65e-05	0.000165	CcSEcCtD
Terbinafine—Pain—Methotrexate—breast cancer	1.64e-05	0.000164	CcSEcCtD
Terbinafine—Vomiting—Capecitabine—breast cancer	1.64e-05	0.000164	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.63e-05	0.000164	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—breast cancer	1.63e-05	0.000163	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—breast cancer	1.63e-05	0.000163	CcSEcCtD
Terbinafine—Rash—Capecitabine—breast cancer	1.62e-05	0.000162	CcSEcCtD
Terbinafine—Dermatitis—Capecitabine—breast cancer	1.62e-05	0.000162	CcSEcCtD
Terbinafine—Headache—Capecitabine—breast cancer	1.61e-05	0.000161	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—breast cancer	1.61e-05	0.000161	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—breast cancer	1.61e-05	0.000161	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—breast cancer	1.58e-05	0.000158	CcSEcCtD
Terbinafine—Nausea—Docetaxel—breast cancer	1.58e-05	0.000158	CcSEcCtD
Terbinafine—Feeling abnormal—Methotrexate—breast cancer	1.58e-05	0.000158	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—breast cancer	1.58e-05	0.000158	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—breast cancer	1.57e-05	0.000157	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—breast cancer	1.56e-05	0.000156	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—breast cancer	1.55e-05	0.000155	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—breast cancer	1.55e-05	0.000155	CcSEcCtD
Terbinafine—Pain—Epirubicin—breast cancer	1.53e-05	0.000153	CcSEcCtD
Terbinafine—Nausea—Capecitabine—breast cancer	1.53e-05	0.000153	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—breast cancer	1.52e-05	0.000152	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—breast cancer	1.52e-05	0.000152	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—breast cancer	1.52e-05	0.000152	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.51e-05	0.000151	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—breast cancer	1.49e-05	0.000149	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—breast cancer	1.48e-05	0.000148	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—breast cancer	1.47e-05	0.000147	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—breast cancer	1.46e-05	0.000146	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—breast cancer	1.44e-05	0.000144	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.43e-05	0.000143	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—breast cancer	1.43e-05	0.000143	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—breast cancer	1.43e-05	0.000143	CcSEcCtD
Terbinafine—Pain—Doxorubicin—breast cancer	1.42e-05	0.000142	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—breast cancer	1.42e-05	0.000142	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—breast cancer	1.42e-05	0.000142	CcSEcCtD
Terbinafine—Hypersensitivity—Methotrexate—breast cancer	1.41e-05	0.000141	CcSEcCtD
Terbinafine—Asthenia—Methotrexate—breast cancer	1.38e-05	0.000138	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—breast cancer	1.37e-05	0.000137	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—breast cancer	1.36e-05	0.000136	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—breast cancer	1.36e-05	0.000136	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—breast cancer	1.32e-05	0.000132	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—breast cancer	1.32e-05	0.000132	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—breast cancer	1.31e-05	0.000131	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—breast cancer	1.31e-05	0.000131	CcSEcCtD
Terbinafine—Diarrhoea—Methotrexate—breast cancer	1.31e-05	0.000131	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—breast cancer	1.29e-05	0.000129	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—breast cancer	1.27e-05	0.000127	CcSEcCtD
Terbinafine—Dizziness—Methotrexate—breast cancer	1.27e-05	0.000127	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—breast cancer	1.23e-05	0.000123	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—breast cancer	1.22e-05	0.000122	CcSEcCtD
Terbinafine—Vomiting—Methotrexate—breast cancer	1.22e-05	0.000122	CcSEcCtD
Terbinafine—Rash—Methotrexate—breast cancer	1.21e-05	0.000121	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—breast cancer	1.21e-05	0.000121	CcSEcCtD
Terbinafine—Headache—Methotrexate—breast cancer	1.2e-05	0.00012	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—breast cancer	1.19e-05	0.000119	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—breast cancer	1.19e-05	0.000119	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—breast cancer	1.17e-05	0.000117	CcSEcCtD
Terbinafine—Vomiting—Epirubicin—breast cancer	1.14e-05	0.000114	CcSEcCtD
Terbinafine—Nausea—Methotrexate—breast cancer	1.14e-05	0.000114	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—breast cancer	1.14e-05	0.000114	CcSEcCtD
Terbinafine—Rash—Epirubicin—breast cancer	1.13e-05	0.000113	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—breast cancer	1.13e-05	0.000113	CcSEcCtD
Terbinafine—Headache—Epirubicin—breast cancer	1.12e-05	0.000112	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—breast cancer	1.1e-05	0.00011	CcSEcCtD
Terbinafine—Nausea—Epirubicin—breast cancer	1.07e-05	0.000107	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—breast cancer	1.06e-05	0.000106	CcSEcCtD
Terbinafine—Rash—Doxorubicin—breast cancer	1.05e-05	0.000105	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—breast cancer	1.05e-05	0.000105	CcSEcCtD
Terbinafine—Headache—Doxorubicin—breast cancer	1.04e-05	0.000104	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—breast cancer	9.86e-06	9.86e-05	CcSEcCtD
Terbinafine—CYP3A4—Metabolism—GPX2—breast cancer	2.16e-06	4.02e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP3A4—breast cancer	2.15e-06	4.01e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NOS3—breast cancer	2.15e-06	4e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.14e-06	3.99e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—FASN—breast cancer	2.13e-06	3.98e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HPGDS—breast cancer	2.13e-06	3.98e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SULT1A1—breast cancer	2.13e-06	3.97e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GPX4—breast cancer	2.13e-06	3.97e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—BCHE—breast cancer	2.13e-06	3.97e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HBA1—breast cancer	2.12e-06	3.95e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—FASN—breast cancer	2.12e-06	3.95e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1B1—breast cancer	2.11e-06	3.94e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—BCHE—breast cancer	2.11e-06	3.93e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC5A5—breast cancer	2.1e-06	3.92e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.09e-06	3.9e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC5A5—breast cancer	2.08e-06	3.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTA1—breast cancer	2.08e-06	3.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—IDH1—breast cancer	2.08e-06	3.88e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.07e-06	3.87e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—COMT—breast cancer	2.07e-06	3.86e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTT1—breast cancer	2.07e-06	3.86e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ACHE—breast cancer	2.07e-06	3.86e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTP1—breast cancer	2.06e-06	3.84e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NAT2—breast cancer	2.06e-06	3.84e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HMOX1—breast cancer	2.03e-06	3.79e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC2A1—breast cancer	2.03e-06	3.78e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NQO1—breast cancer	2.03e-06	3.78e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ITPR1—breast cancer	2.03e-06	3.78e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NCOA1—breast cancer	2.02e-06	3.76e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC2A1—breast cancer	2.01e-06	3.75e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NQO1—breast cancer	2.01e-06	3.75e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP19A1—breast cancer	1.99e-06	3.71e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—STK11—breast cancer	1.99e-06	3.71e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CB—breast cancer	1.98e-06	3.7e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP3A4—breast cancer	1.98e-06	3.69e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.97e-06	3.67e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTGS2—breast cancer	1.96e-06	3.66e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP3A4—breast cancer	1.96e-06	3.66e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP17A1—breast cancer	1.96e-06	3.65e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.95e-06	3.64e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ABCB1—breast cancer	1.95e-06	3.64e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1B1—breast cancer	1.94e-06	3.63e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS1—breast cancer	1.94e-06	3.61e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ENO1—breast cancer	1.94e-06	3.61e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.93e-06	3.6e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1B1—breast cancer	1.93e-06	3.6e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—TYMS—breast cancer	1.91e-06	3.57e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CD—breast cancer	1.91e-06	3.57e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.91e-06	3.56e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.9e-06	3.55e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2D6—breast cancer	1.9e-06	3.54e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NCOR1—breast cancer	1.89e-06	3.53e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—breast cancer	1.89e-06	3.53e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.89e-06	3.53e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.89e-06	3.53e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALB—breast cancer	1.89e-06	3.52e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.87e-06	3.48e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOA2—breast cancer	1.86e-06	3.48e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NCOA1—breast cancer	1.85e-06	3.46e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—COMT—breast cancer	1.85e-06	3.45e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTP1—breast cancer	1.84e-06	3.43e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NCOA1—breast cancer	1.84e-06	3.43e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—STK11—breast cancer	1.83e-06	3.41e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP19A1—breast cancer	1.83e-06	3.41e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CA—breast cancer	1.82e-06	3.4e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HMOX1—breast cancer	1.81e-06	3.38e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GPX1—breast cancer	1.81e-06	3.38e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—STK11—breast cancer	1.81e-06	3.38e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP19A1—breast cancer	1.81e-06	3.38e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ITPR1—breast cancer	1.81e-06	3.38e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—FASN—breast cancer	1.81e-06	3.37e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NOS3—breast cancer	1.81e-06	3.37e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MED12—breast cancer	1.8e-06	3.37e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—DPYD—breast cancer	1.8e-06	3.37e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—BCHE—breast cancer	1.8e-06	3.36e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP1A1—breast cancer	1.79e-06	3.35e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ERCC2—breast cancer	1.78e-06	3.32e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC5A5—breast cancer	1.78e-06	3.32e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALDOA—breast cancer	1.78e-06	3.31e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ABCB1—breast cancer	1.74e-06	3.25e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOA3—breast cancer	1.72e-06	3.22e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC2A1—breast cancer	1.72e-06	3.2e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NQO1—breast cancer	1.72e-06	3.2e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC2A2—breast cancer	1.71e-06	3.19e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTEN—breast cancer	1.71e-06	3.19e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—TYMS—breast cancer	1.71e-06	3.19e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.7e-06	3.17e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—COMT—breast cancer	1.7e-06	3.17e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTP1—breast cancer	1.69e-06	3.15e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.69e-06	3.15e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NCOR1—breast cancer	1.69e-06	3.15e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—breast cancer	1.69e-06	3.15e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—COMT—breast cancer	1.68e-06	3.14e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.68e-06	3.14e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTR—breast cancer	1.68e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CPT1A—breast cancer	1.68e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCG2—breast cancer	1.68e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTP1—breast cancer	1.68e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP3A4—breast cancer	1.67e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—breast cancer	1.67e-06	3.12e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HMOX1—breast cancer	1.67e-06	3.11e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CB—breast cancer	1.67e-06	3.11e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.67e-06	3.11e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ITPR1—breast cancer	1.66e-06	3.1e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HMOX1—breast cancer	1.65e-06	3.08e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTGS2—breast cancer	1.65e-06	3.08e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ITPR1—breast cancer	1.65e-06	3.08e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP1B1—breast cancer	1.65e-06	3.07e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HPGDS—breast cancer	1.64e-06	3.07e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HBA1—breast cancer	1.63e-06	3.05e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GPX1—breast cancer	1.62e-06	3.02e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.61e-06	3.01e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1A1—breast cancer	1.6e-06	2.99e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ABCB1—breast cancer	1.6e-06	2.99e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTT1—breast cancer	1.59e-06	2.98e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ACHE—breast cancer	1.59e-06	2.98e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ERCC2—breast cancer	1.59e-06	2.96e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ABCB1—breast cancer	1.59e-06	2.96e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TYMS—breast cancer	1.57e-06	2.93e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOA1—breast cancer	1.57e-06	2.93e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TYMS—breast cancer	1.56e-06	2.91e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—breast cancer	1.55e-06	2.9e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.55e-06	2.9e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NCOR1—breast cancer	1.55e-06	2.9e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—STK11—breast cancer	1.55e-06	2.89e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP19A1—breast cancer	1.55e-06	2.89e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CAV1—breast cancer	1.54e-06	2.88e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NCOR1—breast cancer	1.54e-06	2.87e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—breast cancer	1.54e-06	2.87e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.54e-06	2.87e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.51e-06	2.82e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ENO1—breast cancer	1.49e-06	2.79e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS1—breast cancer	1.49e-06	2.79e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—breast cancer	1.49e-06	2.79e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—breast cancer	1.49e-06	2.78e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GPX1—breast cancer	1.49e-06	2.78e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GPX1—breast cancer	1.48e-06	2.75e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.47e-06	2.75e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.47e-06	2.75e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.47e-06	2.73e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ERCC2—breast cancer	1.46e-06	2.73e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1A1—breast cancer	1.46e-06	2.72e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.45e-06	2.71e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ERCC2—breast cancer	1.45e-06	2.7e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTEN—breast cancer	1.44e-06	2.69e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—COMT—breast cancer	1.44e-06	2.69e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOA2—breast cancer	1.44e-06	2.68e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTP1—breast cancer	1.43e-06	2.67e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HMOX1—breast cancer	1.41e-06	2.64e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ITPR1—breast cancer	1.41e-06	2.63e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CG—breast cancer	1.41e-06	2.62e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—FASN—breast cancer	1.4e-06	2.6e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—BCHE—breast cancer	1.39e-06	2.59e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CAV1—breast cancer	1.38e-06	2.57e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—breast cancer	1.37e-06	2.56e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.37e-06	2.56e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—breast cancer	1.36e-06	2.54e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ABCB1—breast cancer	1.36e-06	2.53e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TYMS—breast cancer	1.33e-06	2.48e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NQO1—breast cancer	1.33e-06	2.47e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.33e-06	2.47e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOR1—breast cancer	1.32e-06	2.46e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.32e-06	2.46e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—breast cancer	1.32e-06	2.46e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.32e-06	2.45e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.27e-06	2.37e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CAV1—breast cancer	1.27e-06	2.36e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GPX1—breast cancer	1.26e-06	2.35e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CAV1—breast cancer	1.26e-06	2.34e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CG—breast cancer	1.25e-06	2.34e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.25e-06	2.33e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.25e-06	2.33e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ERCC2—breast cancer	1.24e-06	2.31e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CD—breast cancer	1.24e-06	2.31e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALB—breast cancer	1.22e-06	2.28e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOA1—breast cancer	1.21e-06	2.26e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CA—breast cancer	1.21e-06	2.25e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.2e-06	2.24e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—STK11—breast cancer	1.19e-06	2.23e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.19e-06	2.23e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NOS3—breast cancer	1.17e-06	2.18e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—breast cancer	1.16e-06	2.17e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.15e-06	2.15e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.14e-06	2.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—COMT—breast cancer	1.11e-06	2.07e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTP1—breast cancer	1.11e-06	2.06e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.1e-06	2.06e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMOX1—breast cancer	1.09e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALB—breast cancer	1.09e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ITPR1—breast cancer	1.09e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.08e-06	2.01e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CAV1—breast cancer	1.07e-06	2e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTGS2—breast cancer	1.07e-06	1.99e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCB1—breast cancer	1.05e-06	1.95e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NOS3—breast cancer	1.04e-06	1.94e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TYMS—breast cancer	1.03e-06	1.92e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.03e-06	1.91e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CA—breast cancer	1.02e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—breast cancer	1.02e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOR1—breast cancer	1.02e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.02e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.01e-06	1.89e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.01e-06	1.88e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALB—breast cancer	1e-06	1.87e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALB—breast cancer	9.93e-07	1.85e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—breast cancer	9.86e-07	1.84e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CG—breast cancer	9.77e-07	1.82e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GPX1—breast cancer	9.73e-07	1.82e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1A1—breast cancer	9.63e-07	1.8e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CB—breast cancer	9.61e-07	1.79e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NOS3—breast cancer	9.58e-07	1.79e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ERCC2—breast cancer	9.55e-07	1.78e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTGS2—breast cancer	9.52e-07	1.78e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NOS3—breast cancer	9.5e-07	1.77e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTEN—breast cancer	9.31e-07	1.74e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—breast cancer	8.98e-07	1.68e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CB—breast cancer	8.84e-07	1.65e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CB—breast cancer	8.76e-07	1.64e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTGS2—breast cancer	8.76e-07	1.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTGS2—breast cancer	8.68e-07	1.62e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CD—breast cancer	8.59e-07	1.6e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALB—breast cancer	8.48e-07	1.58e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTEN—breast cancer	8.31e-07	1.55e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—breast cancer	8.3e-07	1.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CAV1—breast cancer	8.28e-07	1.55e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NOS3—breast cancer	8.11e-07	1.51e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTEN—breast cancer	7.64e-07	1.43e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTEN—breast cancer	7.57e-07	1.41e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CG—breast cancer	7.54e-07	1.41e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CB—breast cancer	7.49e-07	1.4e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS2—breast cancer	7.42e-07	1.38e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CD—breast cancer	6.63e-07	1.24e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CA—breast cancer	6.56e-07	1.22e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALB—breast cancer	6.55e-07	1.22e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTEN—breast cancer	6.47e-07	1.21e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NOS3—breast cancer	6.26e-07	1.17e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CA—breast cancer	5.86e-07	1.09e-05	CbGpPWpGaD
Terbinafine—Propranolol—CYP1A1—breast cancer	5.79e-07	0.343	CrCbGaD
Terbinafine—CYP3A4—Metabolism—PIK3CB—breast cancer	5.78e-07	1.08e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS2—breast cancer	5.73e-07	1.07e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CA—breast cancer	5.39e-07	1.01e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—breast cancer	5.36e-07	1e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CA—breast cancer	5.34e-07	9.97e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTEN—breast cancer	4.99e-07	9.32e-06	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—breast cancer	4.79e-07	8.93e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CA—breast cancer	4.57e-07	8.52e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—breast cancer	4.4e-07	8.21e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—breast cancer	4.36e-07	8.14e-06	CbGpPWpGaD
Terbinafine—Propranolol—CYP2D6—breast cancer	4.31e-07	0.255	CrCbGaD
Terbinafine—CYP1A2—Metabolism—AKT1—breast cancer	3.73e-07	6.96e-06	CbGpPWpGaD
Terbinafine—Propranolol—CYP3A4—breast cancer	3.7e-07	0.219	CrCbGaD
Terbinafine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.52e-07	6.57e-06	CbGpPWpGaD
Terbinafine—Propranolol—ABCB1—breast cancer	3.08e-07	0.182	CrCbGaD
Terbinafine—CYP3A4—Metabolism—AKT1—breast cancer	2.88e-07	5.37e-06	CbGpPWpGaD
